Viewing data from:

MAGNESIUM SULFATE

ANDA

MAGNESIUM SULFATE | A207967 | B BRAUN MEDICAL INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER(TE code: AP)

Medicare Part B Spending

CMS physician-administered drug spending for Magnesium Sulfate (2023)

Total Spending

$351K

Total Claims

120,619

Beneficiaries

21,025

ASP Price

—

HCPCS: J3475 — Injection, magnesium sulfate, per 500 mg

Source: CMS Medicare Part B Spending by Drug (2023). Shows physician-administered drug costs.

API Supply Chain9 active DMFs2 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

JOST CHEMICAL COMAGNESIUM SULFATE DRIED

DMF 251332011

TOMITA PHARMACEUTICAL CO LTDMAGNESIUM SULFATE HEPTAHYDRATE

DMF 263012012

MACCO ORGANIQUES SROMAGNESIUM SULFATE HEPTAHYDRATE

DMF 311052016

MACCO ORGANIQUES SROMAGNESIUM SULFATE DRIED

DMF 318742017

AVANTOR PERFORMANCE MATERIALS LLCMAGNESIUM SULFATE ANHYDROUS

DMF 335712019

JOST CHEMICAL COMAGNESIUM SULFATE ANHYDROUS

DMF 341002020

GLOBAL CALCIUM PRIVATE LTDMAGNESIUM SULFATE USP

DMF 368732022

MAITHRI DRUGS PRIVATE LTDMAGNESIUM SULFATE DRIED USP

DMF 422362025

EMNAR PHARMA PRIVATE LTDMAGNESIUM SULFATE HEPTAHYDRATE

DMF 433422025

GILES CHEMICAL A DIVISION OF PREMIER MAGNESIA LLCInactiveMAGNESIUM SULFATE HEPTAHYDRATE, USP (PARENTERAL GRADES)

DMF 139601999

TOMITA PHARMACEUTICAL CO LTDInactiveMAGNESIUM SULFATE ANHYDROUS, USP

DMF 329312018

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 2GM/50ML (40MG/ML)

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Apr 26, 2021

No patent or exclusivity listings for this strength.

#002 — 4GM/100ML (40MG/ML)

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Apr 26, 2021

#003 — 4GM/50ML (80MG/ML)

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Apr 26, 2021